Hyperuricemic nephropathy (HN) represents a prevalent complication of hyperuricemia, typified by tubular dysfunction, inflammation, and progressive renal fibrosis with unclear mechanisms. Ferroptosis, an iron-dependent regulated cell death, is implicated in multiple diseases, but has rarely been linked to HN. In this study, we aim to explore the possible role of ferroptosis in HN and its underlying mechanisms.
Results:
We showed that urate oxidase knockout mice, a model of hyperuricemia, exhibited renal impairment with elevated uric acid, creatinine, and blood urea nitrogen levels, accompanied by increased iron deposition and decreased glutathione peroxidase 4 (GPX4) and xCT expressions, suggesting ferroptosis involvement. Ferroptosis inhibitor Ferrostatin-1 (Fer-1) ameliorated renal injury, inflammatory cell infiltration, and fibrosis in these mice. Mechanistically, Fer-1 restored antioxidant protein levels, normalized ferroptosis-associated protein expressions, diminished iron overload and lipid peroxidation, and suppressed inflammatory markers and mitogen-activated protein kinase signaling. In vitro, monosodium urate crystals induced ferroptosis in human kidney 2 cells, characterized by increased lipid peroxidation and iron accumulation. Notably, receptor for advanced glycation end products (RAGE) inhibition alleviated renal injury, inflammation, and fibrosis albeit without directly diminishing ferroptosis. These findings were validated in human hyperuricemia-related kidney disease samples showing increased iron deposition, decreased GPX4, and elevated RAGE expression.
Innovation and Conclusion:
This study suggests that ferroptosis may play a role in the development of renal injury, inflammation, and fibrosis in HN, potentially mediated through RAGE signaling. While RAGE inhibition improved renal injury, it did not directly affect ferroptosis, indicating a complex and context-dependent role of RAGE in kidney injury. These findings highlight ferroptosis and its associated pathways, including RAGE signaling, as potential therapeutic targets for HN. Antioxid. Redox Signal. 43, 56–74.
Get full access to this article
View all access options for this article.
References
1.
BaiY, MengL, HanL, et al.Lipid storage and lipophagy regulates ferroptosis. Biochem Biophys Res Commun, 2019; 508(4):997–1003; doi: 10.1016/j.bbrc.2018.12.039
2.
BaoJ, ShiY, TaoM, et al.Pharmacological inhibition of autophagy by 3-MA attenuates hyperuricemic nephropathy. Clin Sci (Lond), 2018; 132(21):2299–2322; doi: 10.1042/CS20180563
3.
BayırH, DixonSJ, TyurinaYY, et al.Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney. Nat Rev Nephrol, 2023; 19(5):315–336; doi: 10.1038/s41581-023-00689-x
4.
ChenSY, HsuYH, WangSY, et al.Lucidone inhibits autophagy and MDR1 via HMGB1/RAGE/PI3K/Akt signaling pathway in pancreatic cancer cells. Phytother Res, 2022; 36(4):1664–1677; doi: 10.1002/ptr.7385
5.
DalbethN, GoslingAL, GaffoA, et al.Gout. Lancet, 2021; 397(10287):1843–1855; doi: 10.1016/s0140-6736(21)00569-9
6.
DengY, ZengL, LiuH, et al.Silibinin attenuates ferroptosis in acute kidney injury by targeting FTH1. Redox Biol, 2024; 77:103360; doi: 10.1016/j.redox.2024.103360
7.
DengZ, WangY, LiuJ, et al.WBP2 restrains the lysosomal degradation of GPX4 to inhibit ferroptosis in cisplatin-induced acute kidney injury. Redox Biol, 2023; 65:102826; doi: 10.1016/j.redox.2023.102826
8.
DixonSJ, LembergKM, LamprechtMR, et al.Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell, 2012; 149(5):1060–1072; doi: 10.1016/j.cell.2012.03.042
9.
GaoM, MonianP, PanQ, et al.Ferroptosis is an autophagic cell death process. Cell Res, 2016; 26(9):1021–1032; doi: 10.1038/cr.2016.95
10.
GaoM, YiJ, ZhuJ, et al.Role of mitochondria in ferroptosis. Mol Cell, 2019; 73(2):354–363.e3; doi: 10.1016/j.molcel.2018.10.04253;
11.
HouW, XieY, SongX, et al.Autophagy promotes ferroptosis by degradation of ferritin. Autophagy, 2016; 12(8):1425–1428; doi: 10.1080/15548627.2016.1187366
12.
HuJ, GuW, MaN, et al.Leonurine alleviates ferroptosis in cisplatin-induced acute kidney injury by activating the Nrf2 signalling pathway. Br J Pharmacol, 2022a;179(15):3991–4009; doi: 10.1111/bph.15834
13.
HuY, ShiY, ChenH, et al.Blockade of autophagy prevents the progression of hyperuricemic nephropathy through inhibiting nLRP3 inflammasome-mediated pyroptosis. Front Immunol, 2022b;13:858494; doi: 10.3389/fimmu.2022.858494
14.
JoostenLAB, CrişanTO, BjornstadP, et al.Asymptomatic hyperuricaemia: A silent activator of the innate immune system. Nat Rev Rheumatol, 2020; 16(2):75–86; doi: 10.1038/s41584-019-0334-3
15.
JungSW, KimSM, KimYG, et al.Uric acid and inflammation in kidney disease. Am J Physiol Renal Physiol, 2020; 318(6):F1327–Ff1340; doi: 10.1152/ajprenal.00272.2019
16.
KangR, TangD, LotzeMT, et al.RAGE regulates autophagy and apoptosis following oxidative injury. Autophagy, 2011; 7(4):442–444; doi: 10.4161/auto.7.4.14681
17.
KimS, KangSW, JooJ, et al.Characterization of ferroptosis in kidney tubular cell death under diabetic conditions. Cell Death Dis, 2021; 12(2):160; doi: 10.1038/s41419-021-03452-x
18.
LiD, LiuB, FanY, et al.Nuciferine protects against folic acid-induced acute kidney injury by inhibiting ferroptosis. Br J Pharmacol, 2021; 178(5):1182–1199; doi: 10.1111/bph.15364
19.
LiJH, WangW, HuangXR, et al.Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway. Am J Pathol, 2004; 164(4):1389–1397; doi: 10.1016/s0002-9440(10)63225-7
20.
LiS, LiaoZ, YinH, et al.G3BP1 coordinates lysophagy activity to protect against compression-induced cell ferroptosis during intervertebral disc degeneration. Cell Prolif, 2023a;56(3):e13368; doi: 10.1111/cpr.13368
21.
LiY, QinM, ZhongW, et al.RAGE promotes dysregulation of iron and lipid metabolism in alcoholic liver disease. Redox Biol, 2023b;59:102559; doi: 10.1016/j.redox.2022.102559
22.
LiuB, SunT, LiH, et al.Proximal tubular RAGE mediated the renal fibrosis in UUO model mice via upregulation of autophagy. Cell Death Dis, 2022a;13(4):399; doi: 10.1038/s41419-022-04856-z
23.
LiuJ, YangM, KangR, et al.Autophagic degradation of the circadian clock regulator promotes ferroptosis. Autophagy, 2019; 15(11):2033–2035; doi: 10.1080/15548627.2019.1659623
24.
LiuJ, ZhuS, ZengL, et al.DCN released from ferroptotic cells ignites AGER-dependent immune responses. Autophagy, 2021; 18(9):2036–2049; doi: 10.1080/15548627.2021.2008692
25.
LiuN, LiangY, WeiT, et al.The role of ferroptosis mediated by NRF2/ERK-regulated ferritinophagy in CdTe QDs-induced inflammation in macrophage. J Hazard Mater, 2022b;436:129043; doi: 10.1016/j.jhazmat.2022.129043
26.
LiuZ, MaC, WangQ, et al.Targeting FAM134B-mediated reticulophagy activates sorafenib-induced ferroptosis in hepatocellular carcinoma. Biochem Biophys Res Commun, 2022c;589:247–253; doi: 10.1016/j.bbrc.2021.12.019
27.
LuJ, DalbethN, YinH, et al.Mouse models for human hyperuricaemia: A critical review. Nat Rev Rheumatol, 2019; 15(7):413–426; doi: 10.1038/s41584-019-0222-x
28.
LuJ, HouX, YuanX, et al.Knockout of the urate oxidase gene provides a stable mouse model of hyperuricemia associated with metabolic disorders. Kidney Int, 2018; 93(1):69–80; doi: 10.1016/j.kint.2017.04.031
29.
MaL, ShenR, JiaoJ, et al.Gasdermin D promotes hyperuricemia-induced renal tubular injury through RIG-I/caspase-1 pathway. iScience, 2023; 26(12):108463; doi: 10.1016/j.isci.2023.108463
30.
MaoC, LiuX, ZhangY, et al.DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature, 2021; 593(7860):586–590; doi: 10.1038/s41586-021-03539-7
31.
MayO, YatimeL, MerleNS, et al.The receptor for advanced glycation end products is a sensor for cell‐free heme. Febs J, 2020; 288(11):3448–3464; doi: 10.1111/febs.15667
32.
MorcosM, SayedAAR, BierhausA, et al.Activation of tubular epithelial cells in diabetic nephropathy. Diabetes, 2002; 51(12):3532–3544; doi: 10.2337/diabetes.51.12.3532
33.
MoujalledD, StrasserA, LiddellJR. Molecular mechanisms of cell death in neurological diseases. Cell Death Differ, 2021; 28(7):2029–2044; doi: 10.1038/s41418-021-00814-y
34.
OldfieldMD, BachLA, ForbesJM, et al.Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest, 2001; 108(12):1853–1863; doi: 10.1172/jci11951
35.
SeibtTM, PronethB, ConradM. Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic Biol Med, 2019; 133:144–152; doi: 10.1016/j.freeradbiomed.2018.09.014
36.
SellmayrM, Hernandez PetzscheMR, MaQ, et al.Only hyperuricemia with crystalluria, but not asymptomatic hyperuricemia, drives progression of chronic kidney disease. J Am Soc Nephrol, 2020; 31(12):2773–2792; doi: 10.1681/ASN.2020040523
37.
ShiX, ZhuangL, ZhaiZ, et al.Polydatin protects against gouty nephropathy by inhibiting renal tubular cell pyroptosis. Int J Rheum Dis, 2023; 26(1):116–123; doi: 10.1111/1756-185x.14463
38.
ShiY, TaoM, MaX, et al.Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy. Cell Death Dis, 2020; 11(6):467; doi: 10.1038/s41419-020-2673-z
39.
SrivastavaA, KazeAD, McMullanCJ, et al.Uric acid and the risks of kidney failure and death in individuals with CKD. Am J Kidney Dis, 2018; 71(3):362–370; doi: 10.1053/j.ajkd.2017.08.017
40.
TangC, LivingstonMJ, LiuZ, et al.Autophagy in kidney homeostasis and disease. Nat Rev Nephrol, 2020; 16(9):489–508; doi: 10.1038/s41581-020-0309-2
41.
TangGY, LiS, XuY, et al.Renal herb formula protects against hyperuricemic nephropathy by inhibiting apoptosis and inflammation. Phytomedicine, 2023; 116:154812; doi: 10.1016/j.phymed.2023.154812
42.
TaoM, ShiY, TangL, et al.Blockade of ERK1/2 by U0126 alleviates uric acid-induced EMT and tubular cell injury in rats with hyperuricemic nephropathy. Am J Physiol Renal Physiol, 2019; 316(4):F660–F673; doi: 10.1152/ajprenal.00480.2018
43.
WangJ, WangY, LiuY, et al.Ferroptosis, a new target for treatment of renal injury and fibrosis in a 5/6 nephrectomy-induced CKD rat model. Cell Death Discov, 2022a;8(1):127; doi: 10.1038/s41420-022-00931-8
WangQ, XiY, ChenB, et al.Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation. Front Pharmacol, 2022b;13:1022539; doi: 10.3389/fphar.2022.907133
46.
WangY, QuanF, CaoQ, et al.Quercetin alleviates acute kidney injury by inhibiting ferroptosis. J Adv Res, 2021; 28:231–243; doi: 10.1016/j.jare.2020.07.007
47.
WeidemannA, BernhardtWM, KlankeB, et al.HIF activation protects from acute kidney injury. J Am Soc Nephrol, 2008; 19(3):486–494; doi: 10.1681/ASN.2007040419
48.
WenQ, LiuJ, KangR, et al.The release and activity of HMGB1 in ferroptosis. Biochem Biophys Res Commun, 2019; 510(2):278–283; doi: 10.1016/j.bbrc.2019.01.090
49.
WuJ, MinikesAM, GaoM, et al.Intercellular interaction dictates cancer cell ferroptosis via NF2–YAP signalling. Nature, 2019; 572(7769):402–406; doi: 10.1038/s41586-019-1426-6
50.
WuM, MaY, ChenX, et al.Hyperuricemia causes kidney damage by promoting autophagy and NLRP3-mediated inflammation in rats with urate oxidase deficiency. Dis Model Mech, 2021; 14(3); doi: 10.1242/dmm.048041
51.
WuX, WakamiyaM, VaishnavS, et al.Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proc Natl Acad Sci U S A, 1994; 91(2):742–746; doi: 10.1073/pnas.91.2.742
52.
XieD, ZhaoH, LuJ, et al.High uric acid induces liver fat accumulation via ROS/JNK/AP-1 signaling. Am J Physiol Endocrinol Metab, 2021; 320(6):E1032–E1043; doi: 10.1152/ajpendo.00518.2020
53.
YanHF, ZouT, TuoQZ, et al.Ferroptosis: Mechanisms and links with diseases. Signal Transduct Target Ther, 2021; 6(1):49; doi: 10.1038/s41392-020-00428-9
54.
YangF, WangZ, ZhangJH, et al.Receptor for Advanced Glycation End-Product Antagonist Reduces Blood–Brain Barrier Damage After Intracerebral Hemorrhage. Stroke, 2015; 46(5):1328–1336; doi: 10.1161/strokeaha.114.008336
55.
YangWS, SriRamaratnamR, WelschME, et al.Regulation of Ferroptotic Cancer Cell Death by GPX4. Cell, 2014; 156(1–2):317–331; doi: 10.1016/j.cell.2013.12.010
56.
YepuriG, ShekhtmanA, Marie SchmidtA, et al.Heme & RAGE: A new opportunistic relationship? Febs J, 2021; 288(11):3424–3427; doi: 10.1111/febs.15723
57.
YuW, XiongY, LiuM, et al.Structural analysis and attenuates hyperuricemic nephropathy of dextran from the Imperata cylindrica Beauv. var. major (Nees) C. E. Hubb. Carbohydr Polym, 2023; 317:121064; doi: 10.1016/j.carbpol.2023.121064
58.
ZhangB, ChenX, RuF, et al.Liproxstatin-1 attenuates unilateral ureteral obstruction-induced renal fibrosis by inhibiting renal tubular epithelial cells ferroptosis. Cell Death Dis, 2021a;12(9):843; doi: 10.1038/s41419-021-04137-1
59.
ZhangL, HeJ, WangJ, et al.Knockout RAGE alleviates cardiac fibrosis through repressing endothelial-to-mesenchymal transition (EndMT) mediated by autophagy. Cell Death Dis, 2021b;12(5):470; doi: 10.1038/s41419-021-03750-4
60.
ZhangM, ZhuX, WuJ, et al.Prevalence of hyperuricemia among chinese adults: Findings from two nationally representative cross-sectional surveys in 2015-16 and 2018-19. Front Immunol, 2021c;12:791983; doi: 10.3389/fimmu.2021.791983
61.
ZhaoZ, WuJ, XuH, et al.XJB-5-131 inhibited ferroptosis in tubular epithelial cells after ischemia-reperfusion injury. Cell Death Dis, 2020; 11(8):629; doi: 10.1038/s41419-020-02871-6
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
